Editorial Comment from Dr Nagata to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high-volume center

Int J Urol. 2022 Sep;29(9):994. doi: 10.1111/iju.14945. Epub 2022 Jun 3.

Author

Masayoshi Nagata¹

Affiliation

¹ Department of Urology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

PMID: 35656749
DOI: 10.1111/iju.14945

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Renal Cell* / pathology
China
Humans
Kidney Neoplasms* / pathology
Nomograms
Prognosis
Thrombosis*